New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease

American Journal of Pathology

Volumn 184, Issue 1, 2014, Pages 42-54

  De Nardo, Dominic ^a   De Nardo, Christine M ^a   Latz, Eicke ^a,b,c  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CRYOPYRIN; GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE;

ALLERGIC ASTHMA; APOPTOSIS; CELL STRESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMAN; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; ION CURRENT; LUNG DISEASE; LUNG FIBROSIS; LYSOSOME; MACROPHAGE; MASS SPECTROMETRY; NATURAL KILLER CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REVIEW;

ANIMALS; CARRIER PROTEINS; HUMANS; INFLAMMASOMES; LUNG DISEASES;

EID: 84890367292     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.09.007     Document Type: Review

References (127)

1. G.B. Toews Cytokines and the lung Eur Respir J Suppl 34 2001 3s 17s
2. F. Martinon, K. Burns, and J. Tschopp The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta Mol Cell 10 2002 417 426
3. D. De Nardo, and E. Latz NLRP3 inflammasomes link inflammation and metabolic disease Trends Immunol 32 2011 373 379
4. J. Bousquet, and N. Khaltaev Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach 2007 WHO Press Geneva pp v, 15, 21
5. C.A. Dinarello Immunological and inflammatory functions of the interleukin-1 family Annu Rev Immunol 27 2009 519 550
6. E. Latz, T.S. Xiao, and A. Stutz Activation and regulation of the inflammasomes Nat Rev Immunol 13 2013 397 411
7. V. Hornung, A. Ablasser, M. Charrel-Dennis, F. Bauernfeind, G. Horvath, D.R. Caffrey, E. Latz, and K.A. Fitzgerald AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC Nature 458 2009 514 518
8. N. Kerur, M.V. Veettil, N. Sharma-Walia, V. Bottero, S. Sadagopan, P. Otageri, and B. Chandran IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi sarcoma-associated herpesvirus infection Cell Host Microbe 9 2011 363 375
9. C. Bryant, and K.A. Fitzgerald Molecular mechanisms involved in inflammasome activation Trends Cell Biol 19 2009 455 464
10. J.A. Duncan, D.T. Bergstralh, Y. Wang, S.B. Willingham, Z. Ye, A.G. Zimmermann, and J.P. Ting Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling Proc Natl Acad Sci USA 104 2007 8041 8046
11. Z. Hu, C. Yan, P. Liu, Z. Huang, R. Ma, C. Zhang, R. Wang, Y. Zhang, F. Martinon, D. Miao, H. Deng, J. Wang, J. Chang, and J. Chai Crystal structure of NLRC4 reveals its autoinhibition mechanism Science 341 2013 172 175
12. A. Mayor, F. Martinon, T. De Smedt, V. Pétrilli, and J. Tschopp A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses Nat Immunol 8 2007 497 503
13. T. Fernandes-Alnemri, J. Wu, J.W. Yu, P. Datta, B. Miller, W. Jankowski, S. Rosenberg, J. Zhang, and E.S. Alnemri The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation Cell Death Differ 14 2007 1590 1604
14. E.A. Miao, J.V. Rajan, and A. Aderem Caspase-1-induced pyroptotic cell death Immunol Rev 243 2011 206 214
15. N. Dalbeth, and D.O. Haskard Mechanisms of inflammation in gout Rheumatology (Oxford) 44 2005 1090 1096
16. F. Martinon Mechanisms of uric acid crystal-mediated autoinflammation Immunol Rev 233 2010 218 232
17. Y. Shi, J.E. Evans, and K.L. Rock Molecular identification of a danger signal that alerts the immune system to dying cells Nature 425 2003 516 521
18. P. Pelegrin, and A. Surprenant Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway J Biol Chem 282 2007 2386 2394
19. E. Latz NOX-free inflammasome activation Blood 116 2010 1393 1394
20. R. van Bruggen, M.Y. Köker, M. Jansen, M. van Houdt, D. Roos, T.W. Kuijpers, and T.K. van den Berg Human NLRP3 inflammasome activation is Nox1-4 independent Blood 115 2010 5398 5400
21. R. Zhou, A.S. Yazdi, P. Menu, and J. Tschopp A role for mitochondria in NLRP3 inflammasome activation [Erratum appeared in Nature 2011, 475:122] Nature 469 2011 221 225
22. H. Wen, D. Gris, Y. Lei, S. Jha, L. Zhang, M.T. Huang, W.J. Brickey, and J.P. Ting Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling Nat Immunol 12 2011 408 415
23. K. Nakahira, J.A. Haspel, V.A. Rathinam, S.J. Lee, T. Dolinay, H.C. Lam, J.A. Englert, M. Rabinovitch, M. Cernadas, H.P. Kim, K.A. Fitzgerald, S.W. Ryter, and A.M. Choi Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome Nat Immunol 12 2011 222 230
24. F. Bauernfeind, E. Bartok, A. Rieger, L. Franchi, G. Núñez, and V. Hornung Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome J Immunol 187 2011 613 617
25. V. Hornung, F. Bauernfeind, A. Halle, E.O. Samstad, H. Kono, K.L. Rock, K.A. Fitzgerald, and E. Latz Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization Nat Immunol 9 2008 847 856
26. A. Halle, V. Hornung, G.C. Petzold, C.R. Stewart, B.G. Monks, T. Reinheckel, K.A. Fitzgerald, E. Latz, K.J. Moore, and D.T. Golenbock The NALP3 inflammasome is involved in the innate immune response to amyloid-beta Nat Immunol 9 2008 857 865
27. P. Duewell, H. Kono, K.J. Rayner, C.M. Sirois, G. Vladimer, F.G. Bauernfeind, G.S. Abela, L. Franchi, G. Núñez, M. Schnurr, T. Espevik, E. Lien, K.A. Fitzgerald, K.L. Rock, K.J. Moore, S.D. Wright, V. Hornung, and E. Latz NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals [Erratum appeared in Nature 2010, 466:652] Nature 464 2010 1357 1361
28. J.N. Finger, J.D. Lich, L.C. Dare, M.N. Cook, K.K. Brown, C. Duraiswami, J. Bertin, and P.J. Gough Autolytic proteolysis within the function to find domain (FIIND) is required for NLRP1 inflammasome activity J Biol Chem 287 2012 25030 25037
29. B.C. Frew, V.R. Joag, and J. Mogridge Proteolytic processing of Nlrp1b is required for inflammasome activity PLoS Pathog 8 2012 e1002659
30. T. Murakami, J. Ockinger, J. Yu, V. Byles, A. McColl, A.M. Hofer, and T. Horng Critical role for calcium mobilization in activation of the NLRP3 inflammasome Proc Natl Acad Sci USA 109 2012 11282 11287
31. G.S. Lee, N. Subramanian, A.I. Kim, I. Aksentijevich, R. Goldbach-Mansky, D.B. Sacks, R.N. Germain, D.L. Kastner, and J.J. Chae The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP Nature 492 2012 123 127
32. M. Rossol, M. Pierer, N. Raulien, D. Quandt, U. Meusch, K. Rothe, K. Schubert, T. Schöneberg, M. Schaefer, U. Krügel, S. Smajilovic, H. Bräuner-Osborne, C. Baerwald, and U. Wagner Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors Nat Commun 3 2012 1329
33. V. Pétrilli, S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration Cell Death Differ 14 2007 1583 1589
34. D. Perregaux, and C.A. Gabel Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity J Biol Chem 269 1994 15195 15203
35. + efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter Immunity 38 2013 1142 1153
36. T. Misawa, M. Takahama, T. Kozaki, H. Lee, J. Zou, T. Saitoh, and S. Akira Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome Nat Immunol 14 2013 454 460
37. N. Subramanian, K. Natarajan, M.R. Clatworthy, Z. Wang, and R.N. Germain The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation Cell 153 2013 348 361
38. D. Malinska, S.R. Mirandola, and W.S. Kunz Mitochondrial potassium channels and reactive oxygen species FEBS Lett 584 2010 2043 2048
39. K. Shimada, T.R. Crother, J. Karlin, J. Dagvadorj, N. Chiba, S. Chen, V.K. Ramanujan, A.J. Wolf, L. Vergnes, D.M. Ojcius, A. Rentsendorj, M. Vargas, C. Guerrero, Y. Wang, K.A. Fitzgerald, D.M. Underhill, T. Town, and M. Arditi Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis Immunity 36 2012 401 414
40. S.S. Iyer, Q. He, J.R. Janczy, E.I. Elliott, Z. Zhong, A.K. Olivier, J.J. Sadler, V. Knepper-Adrian, R. Han, L. Qiao, S.C. Eisenbarth, W.M. Nauseef, S.L. Cassel, and F.S. Sutterwala Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation Immunity 39 2013 311 323
41. F.G. Bauernfeind, G. Horvath, A. Stutz, E.S. Alnemri, K. MacDonald, D. Speert, T. Fernandes-Alnemri, J. Wu, B.G. Monks, K.A. Fitzgerald, V. Hornung, and E. Latz Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression J Immunol 183 2009 787 791
42. L. Franchi, T. Eigenbrod, and G. Núñez Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation J Immunol 183 2009 792 796
43. C. Juliana, T. Fernandes-Alnemri, S. Kang, A. Farias, F. Qin, and E.S. Alnemri Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation J Biol Chem 287 2012 36617 36622
44. F. Bauernfeind, A. Rieger, F.A. Schildberg, P.A. Knolle, J.L. Schmid-Burgk, and V. Hornung NLRP3 inflammasome activity is negatively controlled by miR-223 J Immunol 189 2012 4175 4181
45. M. Haneklaus, M. Gerlic, M. Kurowska-Stolarska, A.A. Rainey, D. Pich, I.B. McInnes, W. Hammerschmidt, L.A. O'Neill, and S.L. Masters Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1beta production J Immunol 189 2012 3795 3799
46. B.F. Py, M.S. Kim, H. Vakifahmetoglu-Norberg, and J. Yuan Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity Mol Cell 49 2013 331 338
47. O. Gross, H. Poeck, M. Bscheider, C. Dostert, N. Hannesschläger, S. Endres, G. Hartmann, A. Tardivel, E. Schweighoffer, V. Tybulewicz, A. Mocsai, J. Tschopp, and J. Ruland Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence Nature 459 2009 433 436
48. B. Lu, T. Nakamura, K. Inouye, J. Li, Y. Tang, P. Lundbäck, S.I. Valdes-Ferrer, P.S. Olofsson, T. Kalb, J. Roth, Y. Zou, H. Erlandsson-Harris, H. Yang, J.P. Ting, H. Wang, U. Andersson, D.J. Antoine, S.S. Chavan, G.S. Hotamisligil, and K.J. Tracey Novel role of PKR in inflammasome activation and HMGB1 release Nature 488 2012 670 674
49. Y. He, L. Franchi, and G. Núñez The protein kinase PKR is critical for LPS-induced iNOS production but dispensable for inflammasome activation in macrophages Eur J Immunol 43 2013 1147 1152
50. Y.N. Gong, X. Wang, J. Wang, Z. Yang, S. Li, J. Yang, L. Liu, X. Lei, and F. Shao Chemical probing reveals insights into the signaling mechanism of inflammasome activation Cell Res 20 2010 1289 1305
51. V. Compan, A. Baroja-Mazo, G. López-Castejón, A.I. Gomez, C.M. Martínez, D. Angosto, M.T. Montero, A.S. Herranz, E. Bazán, D. Reimers, V. Mulero, and P. Pelegrín Cell volume regulation modulates NLRP3 inflammasome activation Immunity 37 2012 487 500
52. Y. Qu, S. Misaghi, A. Izrael-Tomasevic, K. Newton, L.L. Gilmour, M. Lamkanfi, S. Louie, N. Kayagaki, J. Liu, L. Komuves, J.E. Cupp, D. Arnott, D. Monack, and V.M. Dixit Phosphorylation of NLRC4 is critical for inflammasome activation Nature 490 2012 539 542
53. B.B. Mishra, V.A. Rathinam, G.W. Martens, A.J. Martinot, H. Kornfeld, K.A. Fitzgerald, and C.M. Sassetti Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1beta Nat Immunol 14 2013 52 60
54. E. Hernandez-Cuellar, K. Tsuchiya, H. Hara, R. Fang, S. Sakai, I. Kawamura, S. Akira, and M. Mitsuyama Cutting edge: nitric oxide inhibits the NLRP3 inflammasome J Immunol 189 2012 5113 5117
55. G. Guarda, M. Zenger, A.S. Yazdi, K. Schroder, I. Ferrero, P. Menu, A. Tardivel, C. Mattmann, and J. Tschopp Differential expression of NLRP3 among hematopoietic cells J Immunol 186 2011 2529 2534
56. E. Gwyer Findlay, and T. Hussell Macrophage-mediated inflammation and disease: a focus on the lung Mediators Inflamm 2012 2012 140937
57. T.S. Heng, and M.W. Painter The Immunological Genome Project: networks of gene expression in immune cells Nat Immunol 9 2008 1091 1094
58. P.M. Peeters, T.N. Perkins, E.F. Wouters, B.T. Mossman, and N.L. Reynaert Silica induces NLRP3 inflammasome activation in human lung epithelial cells Part Fibre Toxicol 10 2013 3
59. H.B. Tran, M.D. Lewis, L.W. Tan, S.E. Lester, L.M. Baker, J. Ng, M.A. Hamilton-Bruce, C.L. Hill, S.A. Koblar, M. Rischmueller, R.E. Ruffin, P.J. Wormald, P.D. Zalewski, and C.J. Lang Immunolocalization of NLRP3 inflammasome in normal murine airway epithelium and changes following induction of ovalbumin-induced airway inflammation J Allergy (Cairo) 2012 2012 819176
60. J.K. Taubenberger, and D.M. Morens The pathology of influenza virus infections Annu Rev Pathol 3 2008 499 522
61. I.C. Allen, M.A. Scull, C.B. Moore, E.K. Holl, E. McElvania-TeKippe, D.J. Taxman, E.H. Guthrie, R.J. Pickles, and J.P. Ting The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA Immunity 30 2009 556 565
62. P.G. Thomas, P. Dash, J.R. Aldridge Jr., A.H. Ellebedy, C. Reynolds, A.J. Funk, W.J. Martin, M. Lamkanfi, R.J. Webby, K.L. Boyd, P.C. Doherty, and T.D. Kanneganti The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1 Immunity 30 2009 566 575
63. T. Ichinohe, H.K. Lee, Y. Ogura, R. Flavell, and A. Iwasaki Inflammasome recognition of influenza virus is essential for adaptive immune responses J Exp Med 206 2009 79 87
64. J.L. McAuley, M.D. Tate, C.J. Mackenzie-Kludas, A. Pinar, W. Zeng, A. Stutz, E. Latz, L.E. Brown, and A. Mansell Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease PLoS Pathog 9 2013 e1003392
65. B. Guillot, P. Portalès, A.D. Thanh, S. Merlet, O. Dereure, J. Clot, and P. Corbeau The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment Br J Dermatol 152 2005 690 696
66. A. Pichlmair, O. Schulz, C.P. Tan, T.I. Naslund, P. Liljeström, F. Weber, and C. Reis e Sousa RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates Science 314 2006 997 1001
67. V.A. Rathinam, S.K. Vanaja, L. Waggoner, A. Sokolovska, C. Becker, L.M. Stuart, J.M. Leong, and K.A. Fitzgerald TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by Gram-negative bacteria Cell 150 2012 606 619
68. B.T. Mossman, and A. Churg Mechanisms in the pathogenesis of asbestosis and silicosis Am J Respir Crit Care Med 157 1998 1666 1680
69. S.L. Cassel, S.C. Eisenbarth, S.S. Iyer, J.J. Sadler, O.R. Colegio, L.A. Tephly, A.B. Carter, P.B. Rothman, R.A. Flavell, and F.S. Sutterwala The Nalp3 inflammasome is essential for the development of silicosis Proc Natl Acad Sci USA 105 2008 9035 9040
70. C. Dostert, V. Pétrilli, R. Van Bruggen, C. Steele, B.T. Mossman, and J. Tschopp Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica Science 320 2008 674 677
71. R.E. Smith, R.M. Strieter, S.H. Phan, and S.L. Kunkel C-C chemokines: novel mediators of the profibrotic inflammatory response to bleomycin challenge Am J Respir Cell Mol Biol 15 1996 693 702
72. P. Gasse, C. Mary, I. Guenon, N. Noulin, S. Charron, S. Schnyder-Candrian, B. Schnyder, S. Akira, V.F. Quesniaux, V. Lagente, B. Ryffel, and I. Couillin IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice J Clin Invest 117 2007 3786 3799
73. P. Gasse, N. Riteau, S. Charron, S. Girre, L. Fick, V. Pétrilli, J. Tschopp, V. Lagente, V.F. Quesniaux, B. Ryffel, and I. Couillin Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis Am J Respir Crit Care Med 179 2009 903 913
74. M.T. Kuipers, H. Aslami, J.R. Janczy, K.F. van der Sluijs, A.P. Vlaar, E.K. Wolthuis, G. Choi, J.J. Roelofs, R.A. Flavell, F.S. Sutterwala, P. Bresser, J.C. Leemans, T. van der Poll, M.J. Schultz, and C.W. Wieland Ventilator-induced lung injury is mediated by the NLRP3 inflammasome Anesthesiology 116 2012 1104 1115
75. N. Riteau, P. Gasse, L. Fauconnier, A. Gombault, M. Couegnat, L. Fick, J. Kanellopoulos, V.F. Quesniaux, S. Marchand-Adam, B. Crestani, B. Ryffel, and I. Couillin Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis Am J Respir Crit Care Med 182 2010 774 783
76. M. Bruchard, G. Mignot, V. Derangère, F. Chalmin, A. Chevriaux, F. Végran, W. Boireau, B. Simon, B. Ryffel, J.L. Connat, J. Kanellopoulos, F. Martin, C. Rébé, L. Apetoh, and F. Ghiringhelli Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth Nat Med 19 2013 57 64
77. P.J. Barnes Immunology of asthma and chronic obstructive pulmonary disease Nat Rev Immunol 8 2008 183 192
78. S.C. Eisenbarth, D.A. Piggott, J.W. Huleatt, I. Visintin, C.A. Herrick, and K. Bottomly Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen J Exp Med 196 2002 1645 1651
79. M. Idzko, H. Hammad, M. van Nimwegen, M. Kool, M.A. Willart, F. Muskens, H.C. Hoogsteden, W. Luttmann, D. Ferrari, F. Di Virgilio, J.C. Virchow Jr., and B.N. Lambrecht Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells Nat Med 13 2007 913 919
80. S.S. Thomas, and S.K. Chhabra A study on the serum levels of interleukin-1beta in bronchial asthma J Indian Med Assoc 101 2003 282 284, 286 passim
81. S. Konno, Y. Gonokami, M. Kurokawa, K. Kawazu, K. Asano, K. Okamoto, and M. Adachi Cytokine concentrations in sputum of asthmatic patients Int Arch Allergy Immunol 109 1996 73 78
82. D.H. Broide, M. Lotz, A.J. Cuomo, D.A. Coburn, E.C. Federman, and S.I. Wasserman Cytokines in symptomatic asthma airways J Allergy Clin Immunol 89 1992 958 967
83. X. Dai, K. Sayama, M. Tohyama, Y. Shirakata, Y. Hanakawa, S. Tokumaru, L. Yang, S. Hirakawa, and K. Hashimoto Mite allergen is a danger signal for the skin via activation of inflammasome in keratinocytes J Allergy Clin Immunol 127 2011 806-814.e1-e4
84. A.G. Besnard, N. Guillou, J. Tschopp, F. Erard, I. Couillin, Y. Iwakura, V. Quesniaux, B. Ryffel, and D. Togbe NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant Allergy 66 2011 1047 1057
85. S.C. Eisenbarth, O.R. Colegio, W. O'Connor, F.S. Sutterwala, and R.A. Flavell Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants Nature 453 2008 1122 1126
86. M. Kool, M.A. Willart, M. van Nimwegen, I. Bergen, P. Pouliot, J.C. Virchow, N. Rogers, F. Osorio, C. Reis e Sousa, H. Hammad, and B.N. Lambrecht An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma Immunity 34 2011 527 540
87. I.C. Allen, C.M. Jania, J.E. Wilson, E.M. Tekeppe, X. Hua, W.J. Brickey, M. Kwan, B.H. Koller, S.L. Tilley, and J.P. Ting Analysis of NLRP3 in the development of allergic airway disease in mice J Immunol 188 2012 2884 2893
88. M. Kool, V. Pétrilli, T. De Smedt, A. Rolaz, H. Hammad, M. van Nimwegen, I.M. Bergen, R. Castillo, B.N. Lambrecht, and J. Tschopp Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome J Immunol 181 2008 3755 3759
89. J.L. Ather, K. Ckless, R. Martin, K.L. Foley, B.T. Suratt, J.E. Boyson, K.A. Fitzgerald, R.A. Flavell, S.C. Eisenbarth, and M.E. Poynter Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice J Immunol 187 2011 64 73
90. T.L. Wu, P.Y. Chang, K.C. Tsao, C.F. Sun, L.L. Wu, and J.T. Wu A panel of multiple markers associated with chronic systemic inflammation and the risk of atherogenesis is detectable in asthma and chronic obstructive pulmonary disease J Clin Lab Anal 21 2007 367 371
91. F. Ozseker, S. Buyukozturk, B. Depboylu, D. Yilmazbayhan, E. Karayigit, A. Gelincik, S. Genc, B. Colakoglu, M. Dal, and H. Issever Serum amyloid A (SAA) in induced sputum of asthmatics: a new look to an old marker Int Immunopharmacol 6 2006 1569 1576
92. M. Sawada, T. Kawayama, H. Imaoka, Y. Sakazaki, H. Oda, S. Takenaka, Y. Kaku, K. Azuma, M. Tajiri, N. Edakuni, M. Okamoto, S. Kato, and T. Hoshino IL-18 induces airway hyperresponsiveness and pulmonary inflammation via CD4+ T cell and IL-13 PLoS One 8 2013 e54623
93. M. Decramer, W. Janssens, and M. Miravitlles Chronic obstructive pulmonary disease Lancet 379 2012 1341 1351
94. E. Mortaz, G. Folkerts, F.P. Nijkamp, and P.A. Henricks ATP and the pathogenesis of COPD Eur J Pharmacol 638 2010 1 4
95. B. Kosmider, E.M. Messier, H.W. Chu, and R.J. Mason Human alveolar epithelial cell injury induced by cigarette smoke PLoS One 6 2011 e26059
96. P.J. Barnes, S.D. Shapiro, and R.A. Pauwels Chronic obstructive pulmonary disease: molecular and cellular mechanisms Eur Respir J 22 2003 672 688
97. M.A. Birrell, and S. Eltom The role of the NLRP3 inflammasome in the pathogenesis of airway disease Pharmacol Ther 130 2011 364 370
98. A.A. Wanderer Interleukin-1beta targeted therapy in severe persistent asthma (SPA) and chronic obstructive pulmonary disease (COPD): proposed similarities between biphasic pathobiology of SPA/COPD and ischemia-reperfusion injury Isr Med Assoc J 10 2008 837 842
99. W.G. Kuschner, A. D'Alessandro, H. Wong, and P.D. Blanc Dose-dependent cigarette smoking-related inflammatory responses in healthy adults Eur Respir J 9 1996 1989 1994
100. S.D. Aaron, J.B. Angel, M. Lunau, K. Wright, C. Fex, N. Le Saux, and R.E. Dales Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease Am J Respir Crit Care Med 163 2001 349 355
101. K.F. Chung Cytokines in chronic obstructive pulmonary disease Eur Respir J Suppl 34 2001 50s 59s
102. U. Lappalainen, J.A. Whitsett, S.E. Wert, J.W. Tichelaar, and K. Bry Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung Am J Respir Cell Mol Biol 32 2005 311 318
103. F.M. Botelho, C.M. Bauer, D. Finch, J.K. Nikota, C.C. Zavitz, A. Kelly, K.N. Lambert, S. Piper, M.L. Foster, J.J. Goldring, J.A. Wedzicha, J. Bassett, J. Bramson, Y. Iwakura, M. Sleeman, R. Kolbeck, A.J. Coyle, A.A. Humbles, and M.R. Stampfli IL-1alpha/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice PLoS One 6 2011 e28457
104. E. Doz, N. Noulin, E. Boichot, I. Guénon, L. Fick, M. Le Bert, V. Lagente, B. Ryffel, B. Schnyder, V. Quesniaux, and I. Couillin Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent J Immunol 180 2008 1169 1178
105. N.S. Pauwels, K.R. Bracke, L.L. Dupont, G.R. Van Pottelberge, S. Provoost, T. Vanden Berghe, P. Vandenabeele, B.N. Lambrecht, G.F. Joos, and G.G. Brusselle Role of IL-1alpha and the Nlrp3/caspase-1/IL-1beta axis in cigarette smoke-induced pulmonary inflammation and COPD Eur Respir J 38 2011 1019 1028
106. M. Kang, R.J. Homer, A. Gallo, C.G. Lee, K.A. Crothers, S.J. Cho, C. Rochester, H. Cain, G. Chupp, H.J. Yoon, and J.A. Elias IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation J Immunol 178 2007 1948 1959
107. A.M. Petersen, M. Penkowa, M. Iversen, L. Frydelund-Larsen, J.L. Andersen, J. Mortensen, P. Lange, and B.K. Pedersen Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease [Erratum appeared in Lung 2011, 189:519] Lung 185 2007 161 171
108. N. Rovina, E. Dima, C. Gerassimou, A. Kollintza, C. Gratziou, and C. Roussos Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease Respir Med 103 2009 1056 1062
109. H. Imaoka, T. Hoshino, S. Takei, T. Kinoshita, M. Okamoto, T. Kawayama, S. Kato, H. Iwasaki, K. Watanabe, and H. Aizawa Interleukin-18 production and pulmonary function in COPD Eur Respir J 31 2008 287 297
110. T. Hoshino, S. Kato, N. Oka, H. Imaoka, T. Kinoshita, S. Takei, Y. Kitasato, T. Kawayama, T. Imaizumi, K. Yamada, H.A. Young, and H. Aizawa Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13 Am J Respir Crit Care Med 176 2007 49 62
111. A. Churg, S. Zhou, X. Wang, R. Wang, and J.L. Wright The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling Am J Respir Cell Mol Biol 40 2009 482 490
112. S. Eltom, C.S. Stevenson, J. Rastrick, N. Dale, K. Raemdonck, S. Wong, M.C. Catley, M.G. Belvisi, and M.A. Birrell P2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke PLoS One 6 2011 e24097
113. N. Ferhani, S. Letuve, A. Kozhich, O. Thibaudeau, M. Grandsaigne, M. Maret, M.C. Dombret, G.P. Sims, R. Kolbeck, A.J. Coyle, M. Aubier, and M. Pretolani Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease Am J Respir Crit Care Med 181 2010 917 927
114. C. Hou, H. Zhao, L. Liu, W. Li, X. Zhou, Y. Lv, X. Shen, Z. Liang, S. Cai, and F. Zou High mobility group protein B1 (HMGB1) in asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls Mol Med 17 2011 807 815
115. H. Yanai, T. Ban, Z. Wang, M.K. Choi, T. Kawamura, H. Negishi, M. Nakasato, Y. Lu, S. Hangai, R. Koshiba, D. Savitsky, L. Ronfani, S. Akira, M.E. Bianchi, K. Honda, T. Tamura, T. Kodama, and T. Taniguchi HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses Nature 462 2009 99 103
116. M. Yu, H. Wang, A. Ding, D.T. Golenbock, E. Latz, C.J. Czura, M.J. Fenton, K.J. Tracey, and H. Yang HMGB1 signals through Toll-like receptor (TLR) 4 and TLR2 Shock 26 2006 174 179
117. L. Bossaller, P.I. Chiang, C. Schmidt-Lauber, S. Ganesan, W.J. Kaiser, V.A. Rathinam, E.S. Mocarski, D. Subramanian, D.R. Green, N. Silverman, K.A. Fitzgerald, A. Marshak-Rothstein, and E. Latz Cutting edge: FAS (CD95) mediates noncanonical IL-1beta and IL-18 maturation via caspase-8 in an RIP3-independent manner J Immunol 189 2012 5508 5512
118. J. Maelfait, E. Vercammen, S. Janssens, P. Schotte, M. Haegman, S. Magez, and R. Beyaert Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation by caspase-8 J Exp Med 205 2008 1967 1973
119. H. Kono, G.M. Orlowski, Z. Patel, and K.L. Rock The IL-1-dependent sterile inflammatory response has a substantial caspase-1-independent component that requires cathepsin C J Immunol 189 2012 3734 3740
120. F.M. Botelho, J.K. Nikota, C.M. Bauer, M.C. Morissette, Y. Iwakura, R. Kolbeck, D. Finch, A.A. Humbles, and M.R. Stämpfli Cigarette smoke-induced accumulation of lung dendritic cells is interleukin-1alpha-dependent in mice Respir Res 13 2012 81
121. C.J. Chen, H. Kono, D. Golenbock, G. Reed, S. Akira, and K.L. Rock Identification of a key pathway required for the sterile inflammatory response triggered by dying cells Nat Med 13 2007 851 856
122. T. Eigenbrod, J.H. Park, J. Harder, Y. Iwakura, and G. Núñez Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells J Immunol 181 2008 8194 8198
123. O. Gross, A.S. Yazdi, C.J. Thomas, M. Masin, L.X. Heinz, G. Guarda, M. Quadroni, S.K. Drexler, and J. Tschopp Inflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1 Immunity 36 2012 388 400
124. S.L. Demento, S.C. Eisenbarth, H.G. Foellmer, C. Platt, M.J. Caplan, W.M. Saltzman, I. Mellman, M. Ledizet, E. Fikrig, R.A. Flavell, and T.M. Fahmy Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy Vaccine 27 2009 3013 3021
125. M. Yang, K. Flavin, I. Kopf, G. Radics, C.H.A. Hearnden, G.J. McManus, B. Moran, A. Villalta-Cerdas, L.A. Echegoyen, S. Giordani, and E.C. Lavelle Functionalization of carbon nanoparticles modulates inflammatory cell recruitment and NLRP3 inflammasome activation Small 2013 [Epub ahead of print] doi:10.1002/smll.201300481
126. A.S. Yazdi, G. Guarda, N. Riteau, S.K. Drexler, A. Tardivel, I. Couillin, and J. Tschopp Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta Proc Natl Acad Sci USA 107 2010 19449 19454
127. E. Dhimolea Canakinumab MAbs 2 2010 3 13